MLH1 and Leigh syndrome: Patients with dMMR tumors without MLH1 promoter methylation or BRAF variant are candidates for germline testing to establish a diagnosis of LS, as confirmed by presence of a pathogenic/likely pathogenic variant in one of the MMR genes.